The Procter & Gamble Company (PG) Derivative Instruments, Gain (Loss) Recognized in Income, Ineffective Portion and Amount Excluded from Effectiveness Testing, Net

The Procter & Gamble Company Derivative Instruments, Gain (Loss) Recognized in Income, Ineffective Portion and Amount Excluded from Effectiveness Testing, Net

The Procter & Gamble Company (PG) reported Derivative Instruments, Gain (Loss) Recognized in Income, Ineffective Portion and Amount Excluded from Effectiveness Testing, Net of $238.00 million for the 12-month period ending 2023-06-30, per its 10-K filed 2023-08-04.

Discontinued › Income Statement › Other Income

us-gaap:DerivativeInstrumentsGainLossRecognizedInIncomeIneffectivePortionAndAmountExcludedFromEffectivenessTestingNet · last filed 2023-08-04

• The Procter & Gamble Company derivative instruments, gain (loss) recognized in income, ineffective portion and amount excluded from effectiveness testing, net for fiscal 2023 was $238.00M, a 226.03% increase from fiscal 2022.
• The Procter & Gamble Company derivative instruments, gain (loss) recognized in income, ineffective portion and amount excluded from effectiveness testing, net for fiscal 2022 was $73.00M, a 21.67% increase from fiscal 2021.
• The Procter & Gamble Company derivative instruments, gain (loss) recognized in income, ineffective portion and amount excluded from effectiveness testing, net for fiscal 2021 was $60.00M, a 13.04% decline from fiscal 2020.
• The Procter & Gamble Company derivative instruments, gain (loss) recognized in income, ineffective portion and amount excluded from effectiveness testing, net for fiscal 2020 was $69.00M, a 1.43% decline from fiscal 2019.